Carderock Capital Management Inc Perkinelmer Inc Transaction History

Carderock Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$118.07 - $160.96 $1.44 Million - $1.96 Million	-12,199 Reduced 48.64%	12,882 $1.55 Million
Q2 2022 Jul 21, 2022	SELL	$134.91 - $172.49 $593,738 - $759,128	-4,401 Reduced 14.93%	25,081 $3.57 Million
Q1 2022 Apr 28, 2022	SELL	$162.31 - $192.2 $62,813 - $74,381	-387 Reduced 1.3%	29,482 $5.14 Million
Q4 2021 Jan 31, 2022	BUY	$166.66 - $201.06 $3.62 Million - $4.36 Million	21,707 Added 265.95%	29,869 $6.01 Million
Q3 2021 Oct 29, 2021	BUY	$151.98 - $190.5 $1.24 Million - $1.55 Million	8,162 New	8,162 $1.41 Million

576

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Carderock Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Carderock Capital Management Inc with notifications on news.